Continued Access to and Assessment of Long-Term Safety
Phase 3
50
about 4 years
18+
2 sites in FL, NC
What this study is about
This trial is testing a treatment called T-DXd in people with advanced or metastatic cancer. The goal is to see if this treatment is safe for long-term use.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take T-DXd
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of Participants Reporting Treatment-emergent Adverse Events Leading to Study Drug discontinuation and/or Dose Reduction, Treatment-emergent Serious Adverse Events (TESAEs), and Treatment-emergent Adverse Events of Special Interest (AESIs)